Frélii, Inc. cancelled the acquisition of 25% shares of Genecor AI Inc. from Helix Investment Partners LLC.
December 16, 2020
Share
Frélii, Inc. (OTCPK:FRLI) entered into share purchase agreement to acquire 25% shares of Genecor AI Inc. from Helix Investment Partners LLC for $1.4 million on December 17, 2019. Frelii, Inc. will purchase 25 shares of Genecor AI’s common stock and will issue $3.8 million of shares to Helix Investment Partners pursuant to the AI Purchase agreement.
Frélii, Inc. (OTCPK:FRLI) cancelled the acquisition of 25% shares of Genecor AI Inc. from Helix Investment Partners LLC on December 17, 2020.
Frelii, Inc. provides Web-based nutrition and fitness programs based on usersâ genetic data. The Company provides users personalized, deoxyribonucleic acid (DNA)-based diet and nutrition plans and identifies usersâ health risks. Users can upload their raw genetic data by logging into their 23andMe profile and the Companyâs site uploads that data for use by its artificial intelligence (AI)-based algorithm. Its products include KDIR, EZV-200, BLDB Tonic, Keotone-CoCoa and CTV. The Company provides tools, which includes personalized cookbook, meal planning, shopping lists, supplement packages and video workouts. It provides Navii, which is computer learning-based algorithm generates insight about individual genetic health risks, and assists health providers to identify and treat various health concerns. Its wellness plans feature nutrition and fitness plans, supplement recommendations, downloadable menus, recipes, and shopping lists, and virtual personal training.